Dr. Sukhmani Padda, MD
Claim this profileCedars Sinai Medical Center
Studies Lung Cancer
Studies Non-Small Cell Lung Cancer
7 reported clinical trials
12 drugs studied
Area of expertise
1Lung Cancer
Stage IV
EGFR positive
Stage III
2Non-Small Cell Lung Cancer
Stage IV
EGFR positive
ALK positive
Affiliated Hospitals
Clinical Trials Sukhmani Padda, MD is currently running
Bevacizumab + Chemoimmunotherapy + Atezolizumab
for Small Cell Lung Cancer
This clinical trial aims to assess whether the addition of bevacizumab to atezolizumab and chemotherapy can improve response to treatment and progression-free survival in patients with extensive-stage small cell lung cancer (ES-SCLC) with liver metastases. The main questions it aims to answer are: * In patients with ES-SCLC with liver metastases, can bevacizumab in combination with atezolizumab and chemotherapy prolong the length of time that the cancer does not progress? * Is bevacizumab safe and tolerable when combined with atezolizumab and chemotherapy in patients with ES-SCLC and liver metastases? The study treatment includes two phases: * Induction phase: bevacizumab will be administered in combination with atezolizumab and chemotherapy on a 21-day cycle for four cycles. * Maintenance: atezolizumab and bevacizumab will be administered every 21 days for up to 12 months, or until unacceptable toxicity or disease progression. Participants will undergo blood tests every 3 weeks and tumor assessments every 6 weeks.
Recruiting1 award Phase 211 criteria
Lutetium Lu 177 Dotatate
for Lung Carcinoid Tumor
This trial studies the effect of lutetium Lu 177 dotatate in patients with advanced bronchial neuroendocrine tumors. Lutetium Lu 177 dotatate targets cancer cells with radiation, aiming to kill or shrink them while sparing healthy cells. The goal is to see if it works better than the usual treatment. Everolimus has been shown to help patients with various types of neuroendocrine tumors.
Recruiting1 award Phase 210 criteria
More about Sukhmani Padda, MD
Clinical Trial Related8 years of experience running clinical trials · Led 7 trials as a Principal Investigator · 2 Active Clinical TrialsTreatments Sukhmani Padda, MD has experience with
- Sotorasib
- Necitumumab
- Afatinib
- Nab-paclitaxel
- ORIC-101
- CAB-AXL-ADC
Breakdown of trials Sukhmani Padda, MD has run
Lung Cancer
Non-Small Cell Lung Cancer
Lung Adenocarcinoma
Lung Carcinoma
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Sukhmani Padda, MD specialize in?
Sukhmani Padda, MD focuses on Lung Cancer and Non-Small Cell Lung Cancer. In particular, much of their work with Lung Cancer has involved Stage IV patients, or patients who are EGFR positive.
Is Sukhmani Padda, MD currently recruiting for clinical trials?
Yes, Sukhmani Padda, MD is currently recruiting for 2 clinical trials in Los Angeles California. If you're interested in participating, you should apply.
Are there any treatments that Sukhmani Padda, MD has studied deeply?
Yes, Sukhmani Padda, MD has studied treatments such as Sotorasib, Necitumumab, Afatinib.
What is the best way to schedule an appointment with Sukhmani Padda, MD?
Apply for one of the trials that Sukhmani Padda, MD is conducting.
What is the office address of Sukhmani Padda, MD?
The office of Sukhmani Padda, MD is located at: Cedars Sinai Medical Center, Los Angeles, California 90048 United States. This is the address for their practice at the Cedars Sinai Medical Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.